Nuvation Bio Inc. (NUVB) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $305.72M | -34.1% |
| 2024 | $463.79M | -23.4% |
| 2023 | $605.12M | -7.6% |
| 2022 | $655.08M | -12.2% |
| 2021 | $746.00M | +246.8% |
| 2020 | $215.08M | +82.7% |
| 2019 | $117.75M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $305.72M | -34.1% |
| 2024 | $463.79M | -23.4% |
| 2023 | $605.12M | -7.6% |
| 2022 | $655.08M | -12.2% |
| 2021 | $746.00M | +246.8% |
| 2020 | $215.08M | +82.7% |
| 2019 | $117.75M | — |